TRCT
JAGX icon

Tower Research Capital (TRC)’s Jaguar Health JAGX Stock Holding History

Tower Research Capital (TRC)’s Portfolio JAGX Stock Details JAGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.48K Buy
1,160
+1,094
+1,658% +$7.05K ﹤0.01% 4528
2026
Q1 		$856 Sell
66
-47
-42% -$1.03K ﹤0.01% 4765
2025
Q4 		$3.36K Buy
113
+7
+7% +$360 ﹤0.01% 4382
2025
Q3 		$7.88K Buy
106
+56
+112% +$3.79K ﹤0.01% 4075
2025
Q2 		$4.01K Buy
+50
New +$9.12K ﹤0.01% 4397
2024
Q4 		– Sell
-3
Closed -$3.5K – 5850
2024
Q3 		$3.5K Hold
3
– – ﹤0.01% 4834
2024
Q2 		$8.6K Buy
3
+2
+200% +$13.2K ﹤0.01% 4329
2024
Q1 		$5.34K Buy
+1
New +$4.38K ﹤0.01% 4554
2023
Q1 		– Hold
0
– -$3K – 6062
2022
Q4 		– Hold
0
– – – 5199
2022
Q3 		– Hold
0
– – – 6279
2022
Q2 		– Hold
0
– – – 6301
2022
Q1 		– Hold
0
– – – 6330
2021
Q4 		– Hold
0
– – – 5316
2021
Q3 		– Hold
0
– – – 3289
2021
Q2 		– Hold
0
– – – 5213
2021
Q1 		– Hold
0
– -$27K – 5554
2020
Q4 		– Hold
0
– – – 3660
2020
Q3 		– Hold
0
– – – 4182
2016
Q4 		– Hold
0
– -$1K – 4121
2016
Q3 		– Hold
0
– – – 3312
2016
Q2 		– Hold
0
– – – 4164
2016
Q1 		– Hold
0
– – – 3710
2015
Q4 		– Hold
0
– – – 4758
2015
Q3 		– Hold
0
– – – 3628
2015
Q2 		– Hold
0
– – – 3114

Other funds holding JAGX

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Tower Research Capital (TRC)'s JAGX Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Jaguar Health (JAGX) stake by 1,658% in Q2 2026, buying an estimated $7.05K and bringing the position to 1,160 shares worth $3.48K. The position accounts for ﹤0.01% of the portfolio, ranked #4528.

Tower Research Capital (TRC) first reported a position in JAGX in Q1 2024 and has held it in 8 quarters since. The position peaked at $8.6K in Q2 2024. 8 funds tracked by Wall St. Rank hold JAGX as of Q2 2026.

  • Tower Research Capital (TRC) held 1,160 shares of Jaguar Health worth $3.48K as of Q2 2026.
  • Tower Research Capital (TRC) bought 1,094 Jaguar Health shares in Q2 2026, an estimated $7.05K.
  • Jaguar Health made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4528 holding.
  • Tower Research Capital (TRC) first reported a position in Jaguar Health in Q1 2024 and has held it in 8 quarters since.
  • Tower Research Capital (TRC)'s Jaguar Health position peaked at $8.6K in Q2 2024.
  • 8 funds tracked by Wall St. Rank held Jaguar Health as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.